Rate of Death in Fatal Diseases and Lymphocyte Reproductive Activity Normalized to Numbers of Hematopoietic Stem Cells in Blood | Chapter 3 | New Visions in Biological Science Vol. 1

 The goal of this study was to see how distinct reductions in lymphocytopoietic state affect the viability of patients with malignant and non-malignant pathologies, with the expectation of similar outcomes based on widely recognised immune defence theory. The changes in death rates in the adult population between the ages of + (55-62) years are opposite for malignant and non-malignant diseases, indicating a lack of protumor activity as well as the common morphogenic activity of lymphopoiesis due to its physiological weakening rather than the widely held belief that enhancing antitumor immunity is the cause. Flow cytometry was used to investigate the numbers of CD133+ and CD31+ lymphocytes, as well as those in the G2-M phases, in the total fraction of circulating lymphocytes from patients with fatal liver cirrhosis and advanced lung cancer over a long period of conventional treatment with OLT or palliative surgery followed by myelosuppressive chemotherapy. The link between specific reproductive activity, or sRA (G2-M/CD133+), and the number of committed liver a-fetoprotein-positive (AFP+) cells, as measured by exponential approximation survival curves for both diseases, was studied. Patients with abnormal sRA after OLT and LC patients with excessive sRA above a healthy level had greater death rates and shorter survival times, which coincided with significant immunosuppression produced by anti-rejection and anti-cancer therapy. Rather than cellular immunity, these findings could be explained by the morphogenesis (feeding) activity of circulating lymphocytes directed at both normal and malignant tissues. The variations in sRA could be a useful biomarker for tracking engraftment or tumour growth.

Author (S) Details

Aleksei N. Shoutko
Granov’s Federal Research Center for Radiology and Surgical Technologies, Fundamental Research Department of Saint-Petersburg, Russia.

Olga A. Gerasimova
Granov’s Federal Research Center for Radiology and Surgical Technologies, Outpatient Center for Transplantation, Hepatology, and Nephrology, Saint-Petersburg, Russia.

Viktor F. Mus
Granov’s Federal Research Center for Radiology and Surgical Technologies, Group for Lung Cancer Treatment, Saint-Petersburg, Russia.

View Book :- https://stm.bookpi.org/NVBS-V1/article/view/3171

A Concise Clinicopathological Handbook of Diabetes Mellitis | Book Publisher International

 Diabetes mellitus (DM) is one of the most common chronic illnesses worldwide. According to the World Health Organization, about By 2025, Asian developing countries would account for 60% of diabetic patients. Insulin, as well as other hormones, are produced by pancreatic beta cells. Increased blood sugar levels are required for insulin release above basal levels, and insulin, as an anabolic hormone, will aid in the process of glycogenesis, protein synthesis, and glucose uptake in muscles and adipose tissue. Type I Diabetes Mellitus is caused by a complex interaction of inherited, environmental, and immunological variables that lead to immune system dysfunction, pancreatic cell damage, and insulin deficiency. There is strong evidence of lymphocytic insulinitis and cell-mediated autoimmunity, with helper/inducer and cytotoxic/suppressor T lymphocyte subsets, as well as natural killer cells, present. Because of compensatory over-secretion of insulin by pancreatic islets, glucose tolerance remains normal in the early stages despite insulin resistance. The pathophysiology of long-term diabetic consequences such microvascular disease (microangiopathy), retinal disease (retinopathy), kidney disease (nephropathy), and nerve dysfunction (neuropathy) is currently being studied extensively. Pioglitazone and rosiglitazone are rapidly absorbed and mainly bound by serum albumin after oral dosing. Both of these medicines go through CYP450 metabolism, which is mediated by several isozymes. Increased frequency of infections, sepsis, preeclampsia, postpartum haemorrhage, foetal malformations, large newborns, labour irregularities, and unexpected foetal deaths are all maternal problems related with diabetes during pregnancy.

Author(s) Details

Sourya Acharya
Department of Internal Medicine, Datta Meghe Institute of Medical Sciences (Deemed to be University), Jawaharlal Nehru Medical College Sawangi (Meghe), Wardha, Maharashtra, India.

View Book:- https://stm.bookpi.org/ACCHDM/issue/view/282

Age-Specific Features of the Enzymatic Proliferation Markers upon the Cancer of Different Localisations | Chapter 9 | Highlights on Medicine and Medical Research Vol. 10

 The enzyme activity features of thymidilate "salvage route" synthesis and adenosine catabolism in blood serum and cancer tissues from solid nearby tumours of various localizations were compared. The goal of this study was to look at the diagnostic value of thymidilate metabolism enzymes and adenosine deaminase (ADA) activity, as well as their relationship to tumour growth. Methods: The radioisotope technique and spectrophotometry were used to determine enzyme activity in 169 patients' blood serum and lymphocytes. The activity of thymidine phosphorylase in blood serum is lower in cancer patients than in healthy people, according to the findings. It was accompanied by an increase in the activities of thymidine kinase (TK) and adenosine deaminase (ADA). The characteristics of enzyme activity were shown to be related to age and illness stage. The activity of enzymes changed depending on the success of chemotherapy and tumour elimination. The ADA activity properties of lymphocytes can be a useful indicator of their malfunction. Conclusion: Our findings imply that studying individual enzyme activity dynamics in blood serum could be useful for illness recurrence detection and drug treatment optimization.

Author(s) Details

Berta G. Borzenko
Department of Biochemistry, Maxim Gorky Donetsk National Medical University, Donetsk, Ukraine.

Elena M. Bakurova
Department of Biochemistry, Maxim Gorky Donetsk National Medical University, Donetsk, Ukraine.

Kseniia A. Mironova
Department of Biochemistry, Maxim Gorky Donetsk National Medical University, Donetsk, Ukraine.

Ulia D. Tursunova
Department of Biochemistry, Maxim Gorky Donetsk National Medical University, Donetsk, Ukraine.

View Book :- https://stm.bookpi.org/HMMR-V10/article/view/1120